A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus

Since its emergence in 2012, more than 900 laboratory-confirmed cases of Middle East respiratory syndrome (MERS) have been reported with a fatality rate of more than 30%. However, no antigen detection assay for commercial use is available for diagnosis. In this study, the full-length nucleocapsid pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerging microbes & infections 2015-04, Vol.4 (1), p.1-5
Hauptverfasser: Chen, Yixin, Chan, Kwok-Hung, Kang, Yahong, Chen, Honglin, Luk, Hayes KH, Poon, Rosana WS, Chan, Jasper FW, Yuen, Kwok-Yung, Xia, Ningshao, Lau, Susanna KP, Woo, Patrick CY
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5
container_issue 1
container_start_page 1
container_title Emerging microbes & infections
container_volume 4
creator Chen, Yixin
Chan, Kwok-Hung
Kang, Yahong
Chen, Honglin
Luk, Hayes KH
Poon, Rosana WS
Chan, Jasper FW
Yuen, Kwok-Yung
Xia, Ningshao
Lau, Susanna KP
Woo, Patrick CY
description Since its emergence in 2012, more than 900 laboratory-confirmed cases of Middle East respiratory syndrome (MERS) have been reported with a fatality rate of more than 30%. However, no antigen detection assay for commercial use is available for diagnosis. In this study, the full-length nucleocapsid protein (NP) gene of MERS coronavirus (MERS-CoV) was cloned and expressed in Escherichia coli. A MERS-CoV NP capture enzyme-linked immunosorbent assay (ELISA) using two MERS-CoV-NP-specific monoclonal antibodies (MAbs) generated was developed. The ELISA was evaluated using 129 nasopharyngeal aspirates (NPAs) positive for various respiratory viruses and simulated positive NPAs by adding serial dilutions of MERS-CoV. Using a cutoff OD of 0.19, all 129 NPAs positive for respiratory viruses showed very low OD, with a specificity of 100%. For the two simulated MERS-CoV-positive NPAs with serial dilutions of live MERS-CoV, all samples with ≥10 50% tissue culture infective dose (TCID 50 )/0.1 mL showed positive results. For the 10 additional NPAs with 20 and 200 TCID 50 /0.1 mL of live MERS-CoV added, all were positive. A highly sensitive and specific MAbs-based antigen capture ELISA has been developed for MERS. This sensitive and specific antigen capture ELISA should be useful for detection of MERS-CoV in human and dromedaries and in field studies.
doi_str_mv 10.1038/emi.2015.26
format Article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_journals_1791905986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4069899121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-e9d7072c48608306497d6dc939b8dd946d38f89b178cec8424d3f52fad5d0cfa3</originalsourceid><addsrcrecordid>eNp9kc9rFDEUxwex2FJ78i4BL0LZNb9mklyEUloVKr3oOWSTl5oyk6xJZmX-e7NuLVXEd0ke-fDhvXy77hXBa4KZfAdTWFNM-jUdnnUntNWKiJ48f3I_7s5KucetBB444S-6YzpwSuggTzpzgQrEEmrYATLRobIFG3ywranhDiJyUMHWkCIypZgF-ZTR5-DcCOjKlIoylG3Ipqa8oLJEl9MEyKacotmFPJeX3ZE3Y4Gzh_O0-3p99eXy4-rm9sOny4ubleWS1xUoJ7CgrRmwZG1QJdzgrGJqI51TfHBMeqk2REgLVnLKHfM99cb1Dltv2Gn3_uDdzpsJnIVYsxn1NofJ5EUnE_SfLzF803dpp3kveqZ4E7x9EOT0fYZS9RSKhXE0EdJcNBFEMkYl7hv65i_0Ps05tvU05YwLwtvv_o8iQhGFeyX31PmBsjmVksE_jkyw3mesW8Z6n7H-5Xz9dMtH9neiDRgOQIgtqcn8SHl0upplTNlnE20omv3L_BPvXbVo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1791905986</pqid></control><display><type>article</type><title>A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Springer Nature OA Free Journals</source><source>Access via Taylor &amp; Francis (Open Access Collection)</source><source>PubMed Central</source><creator>Chen, Yixin ; Chan, Kwok-Hung ; Kang, Yahong ; Chen, Honglin ; Luk, Hayes KH ; Poon, Rosana WS ; Chan, Jasper FW ; Yuen, Kwok-Yung ; Xia, Ningshao ; Lau, Susanna KP ; Woo, Patrick CY</creator><creatorcontrib>Chen, Yixin ; Chan, Kwok-Hung ; Kang, Yahong ; Chen, Honglin ; Luk, Hayes KH ; Poon, Rosana WS ; Chan, Jasper FW ; Yuen, Kwok-Yung ; Xia, Ningshao ; Lau, Susanna KP ; Woo, Patrick CY</creatorcontrib><description>Since its emergence in 2012, more than 900 laboratory-confirmed cases of Middle East respiratory syndrome (MERS) have been reported with a fatality rate of more than 30%. However, no antigen detection assay for commercial use is available for diagnosis. In this study, the full-length nucleocapsid protein (NP) gene of MERS coronavirus (MERS-CoV) was cloned and expressed in Escherichia coli. A MERS-CoV NP capture enzyme-linked immunosorbent assay (ELISA) using two MERS-CoV-NP-specific monoclonal antibodies (MAbs) generated was developed. The ELISA was evaluated using 129 nasopharyngeal aspirates (NPAs) positive for various respiratory viruses and simulated positive NPAs by adding serial dilutions of MERS-CoV. Using a cutoff OD of 0.19, all 129 NPAs positive for respiratory viruses showed very low OD, with a specificity of 100%. For the two simulated MERS-CoV-positive NPAs with serial dilutions of live MERS-CoV, all samples with ≥10 50% tissue culture infective dose (TCID 50 )/0.1 mL showed positive results. For the 10 additional NPAs with 20 and 200 TCID 50 /0.1 mL of live MERS-CoV added, all were positive. A highly sensitive and specific MAbs-based antigen capture ELISA has been developed for MERS. This sensitive and specific antigen capture ELISA should be useful for detection of MERS-CoV in human and dromedaries and in field studies.</description><identifier>ISSN: 2222-1751</identifier><identifier>EISSN: 2222-1751</identifier><identifier>DOI: 10.1038/emi.2015.26</identifier><identifier>PMID: 26421268</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Animals ; Antibodies, Monoclonal - biosynthesis ; Antibodies, Monoclonal - immunology ; antigen ; Antigens ; Antigens, Viral - analysis ; Camelus ; Coronavirus Infections - diagnosis ; Coronavirus Infections - immunology ; Coronaviruses ; detection ; Disease Reservoirs ; ELISA ; Enzyme-Linked Immunosorbent Assay - methods ; Enzyme-Linked Immunosorbent Assay - standards ; Female ; Humans ; MERS coronavirus ; Mice ; Mice, Inbred BALB C ; Middle East respiratory syndrome ; Middle East Respiratory Syndrome Coronavirus - immunology ; Middle East Respiratory Syndrome Coronavirus - isolation &amp; purification ; Nucleocapsid Proteins - analysis ; Nucleocapsid Proteins - genetics ; Nucleocapsid Proteins - metabolism ; Original ; Respiratory diseases ; Sensitivity and Specificity ; Zoonoses - diagnosis ; Zoonoses - immunology</subject><ispartof>Emerging microbes &amp; infections, 2015-04, Vol.4 (1), p.1-5</ispartof><rights>2015 The Author(s) 2015</rights><rights>Copyright Nature Publishing Group Apr 2015</rights><rights>2015 The Author(s). This work is licensed under the Creative Commons Attribution – Non-Commercial – Share Alike License http://creativecommons.org/licenses/by-nc-sa/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2015 Shanghai Shangyixun Cultural Communication Co., Ltd 2015 Shanghai Shangyixun Cultural Communication Co., Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-e9d7072c48608306497d6dc939b8dd946d38f89b178cec8424d3f52fad5d0cfa3</citedby><cites>FETCH-LOGICAL-c484t-e9d7072c48608306497d6dc939b8dd946d38f89b178cec8424d3f52fad5d0cfa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575394/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575394/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27502,27924,27925,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26421268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Yixin</creatorcontrib><creatorcontrib>Chan, Kwok-Hung</creatorcontrib><creatorcontrib>Kang, Yahong</creatorcontrib><creatorcontrib>Chen, Honglin</creatorcontrib><creatorcontrib>Luk, Hayes KH</creatorcontrib><creatorcontrib>Poon, Rosana WS</creatorcontrib><creatorcontrib>Chan, Jasper FW</creatorcontrib><creatorcontrib>Yuen, Kwok-Yung</creatorcontrib><creatorcontrib>Xia, Ningshao</creatorcontrib><creatorcontrib>Lau, Susanna KP</creatorcontrib><creatorcontrib>Woo, Patrick CY</creatorcontrib><title>A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus</title><title>Emerging microbes &amp; infections</title><addtitle>Emerg Microbes Infect</addtitle><description>Since its emergence in 2012, more than 900 laboratory-confirmed cases of Middle East respiratory syndrome (MERS) have been reported with a fatality rate of more than 30%. However, no antigen detection assay for commercial use is available for diagnosis. In this study, the full-length nucleocapsid protein (NP) gene of MERS coronavirus (MERS-CoV) was cloned and expressed in Escherichia coli. A MERS-CoV NP capture enzyme-linked immunosorbent assay (ELISA) using two MERS-CoV-NP-specific monoclonal antibodies (MAbs) generated was developed. The ELISA was evaluated using 129 nasopharyngeal aspirates (NPAs) positive for various respiratory viruses and simulated positive NPAs by adding serial dilutions of MERS-CoV. Using a cutoff OD of 0.19, all 129 NPAs positive for respiratory viruses showed very low OD, with a specificity of 100%. For the two simulated MERS-CoV-positive NPAs with serial dilutions of live MERS-CoV, all samples with ≥10 50% tissue culture infective dose (TCID 50 )/0.1 mL showed positive results. For the 10 additional NPAs with 20 and 200 TCID 50 /0.1 mL of live MERS-CoV added, all were positive. A highly sensitive and specific MAbs-based antigen capture ELISA has been developed for MERS. This sensitive and specific antigen capture ELISA should be useful for detection of MERS-CoV in human and dromedaries and in field studies.</description><subject>Animals</subject><subject>Antibodies, Monoclonal - biosynthesis</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>antigen</subject><subject>Antigens</subject><subject>Antigens, Viral - analysis</subject><subject>Camelus</subject><subject>Coronavirus Infections - diagnosis</subject><subject>Coronavirus Infections - immunology</subject><subject>Coronaviruses</subject><subject>detection</subject><subject>Disease Reservoirs</subject><subject>ELISA</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>Enzyme-Linked Immunosorbent Assay - standards</subject><subject>Female</subject><subject>Humans</subject><subject>MERS coronavirus</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Middle East respiratory syndrome</subject><subject>Middle East Respiratory Syndrome Coronavirus - immunology</subject><subject>Middle East Respiratory Syndrome Coronavirus - isolation &amp; purification</subject><subject>Nucleocapsid Proteins - analysis</subject><subject>Nucleocapsid Proteins - genetics</subject><subject>Nucleocapsid Proteins - metabolism</subject><subject>Original</subject><subject>Respiratory diseases</subject><subject>Sensitivity and Specificity</subject><subject>Zoonoses - diagnosis</subject><subject>Zoonoses - immunology</subject><issn>2222-1751</issn><issn>2222-1751</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kc9rFDEUxwex2FJ78i4BL0LZNb9mklyEUloVKr3oOWSTl5oyk6xJZmX-e7NuLVXEd0ke-fDhvXy77hXBa4KZfAdTWFNM-jUdnnUntNWKiJ48f3I_7s5KucetBB444S-6YzpwSuggTzpzgQrEEmrYATLRobIFG3ywranhDiJyUMHWkCIypZgF-ZTR5-DcCOjKlIoylG3Ipqa8oLJEl9MEyKacotmFPJeX3ZE3Y4Gzh_O0-3p99eXy4-rm9sOny4ubleWS1xUoJ7CgrRmwZG1QJdzgrGJqI51TfHBMeqk2REgLVnLKHfM99cb1Dltv2Gn3_uDdzpsJnIVYsxn1NofJ5EUnE_SfLzF803dpp3kveqZ4E7x9EOT0fYZS9RSKhXE0EdJcNBFEMkYl7hv65i_0Ps05tvU05YwLwtvv_o8iQhGFeyX31PmBsjmVksE_jkyw3mesW8Z6n7H-5Xz9dMtH9neiDRgOQIgtqcn8SHl0upplTNlnE20omv3L_BPvXbVo</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Chen, Yixin</creator><creator>Chan, Kwok-Hung</creator><creator>Kang, Yahong</creator><creator>Chen, Honglin</creator><creator>Luk, Hayes KH</creator><creator>Poon, Rosana WS</creator><creator>Chan, Jasper FW</creator><creator>Yuen, Kwok-Yung</creator><creator>Xia, Ningshao</creator><creator>Lau, Susanna KP</creator><creator>Woo, Patrick CY</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Ltd</general><general>Nature Publishing Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150401</creationdate><title>A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus</title><author>Chen, Yixin ; Chan, Kwok-Hung ; Kang, Yahong ; Chen, Honglin ; Luk, Hayes KH ; Poon, Rosana WS ; Chan, Jasper FW ; Yuen, Kwok-Yung ; Xia, Ningshao ; Lau, Susanna KP ; Woo, Patrick CY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-e9d7072c48608306497d6dc939b8dd946d38f89b178cec8424d3f52fad5d0cfa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - biosynthesis</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>antigen</topic><topic>Antigens</topic><topic>Antigens, Viral - analysis</topic><topic>Camelus</topic><topic>Coronavirus Infections - diagnosis</topic><topic>Coronavirus Infections - immunology</topic><topic>Coronaviruses</topic><topic>detection</topic><topic>Disease Reservoirs</topic><topic>ELISA</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>Enzyme-Linked Immunosorbent Assay - standards</topic><topic>Female</topic><topic>Humans</topic><topic>MERS coronavirus</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Middle East respiratory syndrome</topic><topic>Middle East Respiratory Syndrome Coronavirus - immunology</topic><topic>Middle East Respiratory Syndrome Coronavirus - isolation &amp; purification</topic><topic>Nucleocapsid Proteins - analysis</topic><topic>Nucleocapsid Proteins - genetics</topic><topic>Nucleocapsid Proteins - metabolism</topic><topic>Original</topic><topic>Respiratory diseases</topic><topic>Sensitivity and Specificity</topic><topic>Zoonoses - diagnosis</topic><topic>Zoonoses - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Yixin</creatorcontrib><creatorcontrib>Chan, Kwok-Hung</creatorcontrib><creatorcontrib>Kang, Yahong</creatorcontrib><creatorcontrib>Chen, Honglin</creatorcontrib><creatorcontrib>Luk, Hayes KH</creatorcontrib><creatorcontrib>Poon, Rosana WS</creatorcontrib><creatorcontrib>Chan, Jasper FW</creatorcontrib><creatorcontrib>Yuen, Kwok-Yung</creatorcontrib><creatorcontrib>Xia, Ningshao</creatorcontrib><creatorcontrib>Lau, Susanna KP</creatorcontrib><creatorcontrib>Woo, Patrick CY</creatorcontrib><collection>Access via Taylor &amp; Francis (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Emerging microbes &amp; infections</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Yixin</au><au>Chan, Kwok-Hung</au><au>Kang, Yahong</au><au>Chen, Honglin</au><au>Luk, Hayes KH</au><au>Poon, Rosana WS</au><au>Chan, Jasper FW</au><au>Yuen, Kwok-Yung</au><au>Xia, Ningshao</au><au>Lau, Susanna KP</au><au>Woo, Patrick CY</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus</atitle><jtitle>Emerging microbes &amp; infections</jtitle><addtitle>Emerg Microbes Infect</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>4</volume><issue>1</issue><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>2222-1751</issn><eissn>2222-1751</eissn><abstract>Since its emergence in 2012, more than 900 laboratory-confirmed cases of Middle East respiratory syndrome (MERS) have been reported with a fatality rate of more than 30%. However, no antigen detection assay for commercial use is available for diagnosis. In this study, the full-length nucleocapsid protein (NP) gene of MERS coronavirus (MERS-CoV) was cloned and expressed in Escherichia coli. A MERS-CoV NP capture enzyme-linked immunosorbent assay (ELISA) using two MERS-CoV-NP-specific monoclonal antibodies (MAbs) generated was developed. The ELISA was evaluated using 129 nasopharyngeal aspirates (NPAs) positive for various respiratory viruses and simulated positive NPAs by adding serial dilutions of MERS-CoV. Using a cutoff OD of 0.19, all 129 NPAs positive for respiratory viruses showed very low OD, with a specificity of 100%. For the two simulated MERS-CoV-positive NPAs with serial dilutions of live MERS-CoV, all samples with ≥10 50% tissue culture infective dose (TCID 50 )/0.1 mL showed positive results. For the 10 additional NPAs with 20 and 200 TCID 50 /0.1 mL of live MERS-CoV added, all were positive. A highly sensitive and specific MAbs-based antigen capture ELISA has been developed for MERS. This sensitive and specific antigen capture ELISA should be useful for detection of MERS-CoV in human and dromedaries and in field studies.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>26421268</pmid><doi>10.1038/emi.2015.26</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2222-1751
ispartof Emerging microbes & infections, 2015-04, Vol.4 (1), p.1-5
issn 2222-1751
2222-1751
language eng
recordid cdi_proquest_journals_1791905986
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Springer Nature OA Free Journals; Access via Taylor & Francis (Open Access Collection); PubMed Central
subjects Animals
Antibodies, Monoclonal - biosynthesis
Antibodies, Monoclonal - immunology
antigen
Antigens
Antigens, Viral - analysis
Camelus
Coronavirus Infections - diagnosis
Coronavirus Infections - immunology
Coronaviruses
detection
Disease Reservoirs
ELISA
Enzyme-Linked Immunosorbent Assay - methods
Enzyme-Linked Immunosorbent Assay - standards
Female
Humans
MERS coronavirus
Mice
Mice, Inbred BALB C
Middle East respiratory syndrome
Middle East Respiratory Syndrome Coronavirus - immunology
Middle East Respiratory Syndrome Coronavirus - isolation & purification
Nucleocapsid Proteins - analysis
Nucleocapsid Proteins - genetics
Nucleocapsid Proteins - metabolism
Original
Respiratory diseases
Sensitivity and Specificity
Zoonoses - diagnosis
Zoonoses - immunology
title A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A28%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20sensitive%20and%20specific%20antigen%20detection%20assay%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus&rft.jtitle=Emerging%20microbes%20&%20infections&rft.au=Chen,%20Yixin&rft.date=2015-04-01&rft.volume=4&rft.issue=1&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=2222-1751&rft.eissn=2222-1751&rft_id=info:doi/10.1038/emi.2015.26&rft_dat=%3Cproquest_infor%3E4069899121%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1791905986&rft_id=info:pmid/26421268&rfr_iscdi=true